FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Don’t Let the Media Paint the Trans Hockey Shooter as MAGA – His X Profile Shows His Politics Were Inanely Contradictory, Even Schizophrenic

Breaking: Armed Man Shot Breaking Into Mar-A-Lago Carrying Fuel Can, Shotgun

Armed man shot and killed after ‘unauthorized entry’ into Mar-a-Lago: Secret Service

Exiled Iranian princess: Islamic regime ‘has never been this close’ to falling, people ‘begging’ Trump to help

Former FBI agent offers new theory about Nancy Guthrie’s disappearance: ‘Personal grievance’

Trump sending US military hospital ship to Greenland to ‘take care’ of sick

Anti-Voter ID Mamdani Pleads with Citizens to Show 2 Forms of ID to Sign Up for Emergency Snow Shoveling

Kentucky Christian Charter Schools Denied Public Funding by State Supreme Court

Third-party spoiler threatens to upend New Hampshire Senate race unless Trump ends ‘war on Crypto’

What’s driving the increase in violent incidents involving transgender individuals? Expert weighs in

WATCH: Top 5 most memorable moments in American State of the Union history

‘Conflict of interest’: Byron Donalds takes financial interest in Bitcoin as he pushes pro-crypto platform

DHS suspends TSA PreCheck, Global Entry as partial government shutdown continues

Grenell calls ice rink vandal a ‘terrorist’ as federal authorities hunt suspect in toxic attack

California woman hospitalized with chemical burns after portable charger explodes while sleeping

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”